gholamreza pourmand | International Congress Form
![]()
Application Code :
762-0117-0009
Created Date : Tuesday, April 18, 2017-13:53 13:53:16Update Date : Sunday, September 24, 2017-13:11 13:11:54
IP Address : 194.225.214.18Submit Date : Sunday, September 24, 2017-13:14 13:14:43Email : gh_pourmand@yahoo.com
Personal Information
|
Name : |
Gholamreza |
|
Surname : |
Pourmand |
|
School/Research center : |
School of Medicine |
|
If you choose other, please name your Research center : |
|
|
Position : |
Professor |
|
Tel : |
+98-21-66348560 |
Information of Congress
|
Title of the Congress : |
European Association of Urology (EAU) 2017 Congress |
|
Title of your Abstract : |
Encapsulating peritoneal sclerosis, A serious complication of peritoneal dialysis |
|
Destination Country : |
United Kingdom |
|
From : |
Friday, March 24, 2017 |
|
To : |
Tuesday, March 28, 2017 |
|
Abstract(Please copy/paste the abstract send to the congress) : |
Abstract:
Background: Chronic Kidney disease is major health issues that might lead to End Stage Renal Disease in which patients need renal replacement therapy (RRT) in order to survive. Peritoneal dialysis (PD) offers the healthiest way for starting RRT, however exposes long term PD patients to a dangerous high mortality complication named Encapsulating peritoneal sclerosis (EPS)
In this study we searched for possible risk factors of EPS.
Methods: Data were collected from two PD centers (shafa and Shariati) covering period 1995 to 2012 and comprised 464 patients .Control group defined as PD patients stayed on PD > 42 month (n=122), and case group was 12 confirmed EPS patients. Associations were analyzed using linear regression analysis with EPS being primary outcome.
Results: Prevalence and incidence of EPS were 2.59% and 8.9 with an incidence of 0.7% patient-years, respectively. The age at start of PD in EPS patients (32.7510.8 year) was significantly lower compared with control group (49.6116.18 year, p=0.0001). The mean duration of PD in EPS and control group were 2494.4940.9 and 1890.2598.8 days (p= 0.002). Control group had 145 episodes of peritonitis during total duration of 7686 patient months (peritonitis rate of 1/53). This was 1/26 with a total 38 episodes of peritonitis during the total duration of 997 patient months (p=0.01) for EPS group. In regression analysis, PD duration, age at PD start and duration of UFF were associated with EPS.
Conclusions: Longer time being on PD, younger age, and higher UFF duration were the risk factors for EPS development. |
|
Keywords of your Abstract : |
chronic kidney disease, end stage renal disease, peritoneal dialysis, peritoneal fibrosis, encapsulating peritoneal sclerosis, |
|
Acceptance Letter : |
http://gsia.tums.ac.ir/images/UserFiles/12026/Forms/762/acceptance letter_1.pdf |
|
The presentation : |
eposter |
|
The Cover of Abstract book : |
http://gsia.tums.ac.ir/images/UserFiles/12026/Forms/762/cover of abstarct book_1.pdf |
|
Published abstract in the abstract book with the related code : |
http://gsia.tums.ac.ir/images/UserFiles/12026/Forms/762/published abstract_1.pdf |
|
Where has your abstract been indexed? : |
ISI |
|
If you choose other, please name : |
|
The Congress Reporting Form
|
How many volunteers were present at the Congress? : |
About 10,000 |
|
Delegates from which countries presented in the congress? : |
1-USA
2-France
3-Spain
4-Belgium
5-Denmark |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
Nursing and the subfields, technology organization in urology, genetics and radiology |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
Since i was the kidney transplant speaker with two presentations, different questions were raised by the attending urologists and proper response was provided accordingly. |
|
If you met staff members, please list their full names & positions. : |
As the vice president of Iranian Urological Association, I attended a summit and met the following:
a. Prof. Christopher Chapple, Secretary General, European Association of Urology
b. Prof. Hendrik Van Poppel , Member of EAU Board
c. Prof. Paulo, Member of EAU Board |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
|
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
As usual |
|
Please give a briefing of your own observations and outcomes of the congress: : |
In a new program based on thematic sessions, well-experienced, distinguished specialists (selected expert speakers) were invited from all parts of the world; routine and seemingly simple issues were raised and discussed from different angles and this was quite interesting and useful. Such programs were held once or a few times a day intensively. |